| à Brassard, Lothar (Chemagen 201102 CEO) |
Chief Executive Officer (CEO) |
PerkinElmer (Group) |
Germany |
| Aarts, Kees (Protix 202202 CEO + Founder) |
Chief Executive Officer (CEO) |
Protix B.V. |
Netherlands |
| Abate, Emmanuel (Danaher 202210 President Genomic Medicine at Cytiva) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
United Kingdom (GB) |
| Abbey, Jeffrey (Jeff) (ImmunOs Therapeutics 202109– COO before Independent Consultant + Novadip Biosciences + Argos Tx) |
Chief Operating Officer (COO) |
ImmunOs Therapeutics AG |
Switzerland |
| Abdellaoui, Hautman (RED Horticulture 202311 CFO) |
Chief Financial Officer (CFO) |
RED Horticulture (Rouge Engineered Designs) (Group) |
France |
| Abdulkin, Pavel (Microcaps 202103 Sales + Business Development) |
Sales Manager / Marketing Manager |
Microcaps AG |
Switzerland |
| Abend, Sven (Lonza 201903– COO of Lonza Specialty Ingredients segment) |
President/Director/Head Business Group/Unit/Division |
Lonza (Group) |
Switzerland |
| Abken, Hinrich (Univ Cologne 201507 Prof at CMMC) |
Professor |
University of Cologne (Universität zu Köln) |
Germany |
| Abou-Jamra, Hoda (Boston BioCapital FZ LLC + TVM Capital MENA 201002 Co-Founder) |
Company Founder |
TVM (Group) |
United Arab Emirates (UAE) |
| Abraham, Eytan (Lonza 201710 RnD Associate Director) |
n. a. |
Lonza (Group) |
Switzerland |
| Abrams, Judith R. (Editas Medicine 201910– CMO before EMD Serono RnD Institute + CorMedix + Celgene + Novo Nordisk) |
Chief Medical Officer (CMO) |
Editas Medicine Inc. (Nasdaq: EDIT) |
United States (USA) |
| Abshagen, Ulrich (Heidelberg Innovation 200503) |
n. a. |
Heidelberg Innovation (Group) |
Germany |
| Aburatani, Yoshihiro (RIKEN 201910 President of RIKEN Innovation Co Ltd) |
President/Director/Head Business Group/Unit/Division |
RIKEN Research Cluster for Innovation (JP) |
Japan |
| Achstetter, Tilmann (Hochschule Bremen 201303 Professor for Inudstrial Microbiology) |
Professor |
University of Applied Sciences Bremen (Hochschule Bremen) |
Germany |
| Ackermann, Bastian (Miltenyi Biotec 201807 Global Product Manager MACSQuant Tyto) |
Product Manager (personnel) |
Miltenyi Biotec (Group) |
Germany |
| Adams, Jan (Apollo Health Ventures 202109– Venture Partner before Merck KGaA + EMBL Ventures) |
Venture Partner |
Apollo Health Ventures (Group) |
Germany |
| Adams, Julian (Gamida Cell 201906 CEO) |
Chief Executive Officer (CEO) |
Gamida Cell Ltd. (Nasdaq: GMDA) |
Israel |
| Adams, Nicholas (Clavis Pharma 201107– CBO before Antisoma since 1999 BusDev Director + Manager + Ciba-Geiga + Eisai) |
Chief Business Officer (CBO) |
Aqualis ASA |
Norway |
| Adams, Thorsten (Sartorius 201705 Director of Product Management for Fermentation Technologies at SSB) |
Product Manager (personnel) |
Sartorius (Group) |
Germany |
| Adams, Timothy M. (Tim) (ObsEva 201701– CFO located in US before Demandware + athenahealth + Cytyc) |
Chief Financial Officer (CFO) |
ObsEva (Group) |
Switzerland |
| Adams, Tom (Pairwise 202308 CEO + Co-Founder before Monsanto 201708 VP Biotechnology) |
Chief Executive Officer (CEO) |
Pairwise (Group) |
United States (USA) |
| Adamski, J. (Helmholtz Zentrum München 200805 Head Gene Analysis Centre) |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Ade, Michael (Strammer 201610 Partner + Top Management Consultant before Euromedica + Cellca + Ingenium) |
n. a. |
Strammer (Group) |
Germany |
| Adelhelm, Karin (Clondiag 200502) |
n. a. |
Abbott (Group) |
Germany |
| Adermann, Knut (AMP Biosimilars AG 201504 COO) |
Chief Technology/Technical Officer (CTO) |
AMP Biosimilars AG |
Germany |
| Adermann, Knut (AMP-Therapeutics GmbH 201210 Managing Director) |
Managing Director |
Spexis (Group) |
Germany |
| Adler-Beutgen, Amalia (Fujifilm 200706 Product Manager Diagnostics) |
n. a. |
Fujifilm (Group) |
Germany |
| Adlkofer, Kathrin (ai:do concepts GmbH 20111– Managing Director before Norgenta 2005–201202 Managing Director) |
Managing Director |
Cellbox Solutions (Group) |
Germany |
| Adomakah, Nicholas (Novartis 202301 Sandoz Anti-infectives Global Medical Lead) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Germany |
| Adomat, Jens (Analytik Jena 1990–201312 Deputy Chairman of Executive Management Board + Co-founder LEFT 12/13) |
Board member, executive |
Endress+Hauser (Group) |
Germany |
| Adorján, Péter (Centogene 201502– Chief Business Development Officer before Epigenomics) |
Business Development Manager / Strategy Manager |
Centogene (Group) |
Germany |
| Aebersold, Ruedi (ETH Zurich 2005c– Professor Systems Biology before Institute of Systems Biology Seattle) |
Professor |
ETH Zürich (ETHZ) |
Switzerland |
| Aebischer, Patrick (Ecole Polytechnique Fédérale 200808) |
n. a. |
EPFL (Ecole Polytechnique Fédérale de Lausanne) |
Switzerland |
| Afeyan, Noubar (Flagship Ventures 200603 managing partner + CEO) |
Chief Executive Officer (CEO) |
Flagship Pioneering |
United States (USA) |
| Affentranger, Anton (Affentranger Associates 200803 CEO + Senior Partner + founder before Roche CFO) |
Chief Executive Officer (CEO) |
Affentranger Associates S.A. |
Switzerland |
| Afflerbach, Henning (Coral BioNet 201205 CBO at Scil Proteins) |
Chief Business Officer (CBO) |
UV-Cap (Vetter family office) (Group) |
Germany |
| Afonso, Carlos (Univ Rouen 201606) |
Laboratory Manager (industry) |
University of Rouen (Université de Rouen) |
France |
| Agamirzian, Igor (Russia (govt) 201203 CEO of RVC Russian Venture Capital) |
Chief Executive Officer (CEO) |
Russia (govt) |
Russian Federation |
| Agarwala, Sandip (Blue Owl Capital 202208 Managing Director at Owl Rock) |
Managing Director |
Blue Owl Capital (Group) |
United States (USA) |
| Agneter, Doris (Niederösterreich (govt) 200511 Managing Director of N.vest + Tecnet Equity) |
Managing Director |
Niederösterreich (govt region) |
Austria |
| Agrawal, Bhuwnesh (Sysmex 202004– Managing Director (CEO) of Sysmex Inostics GmbH before Eppendorf + Vela Dx + Roche) |
Managing Director |
Sysmex (Group) |
Germany |
| Agrawal, Sudhir (Idera 200612 CEO + CSO) |
Chief Executive Officer (CEO) |
Idera Pharmaceuticals Inc. (Nasdaq: IDRA) |
United States (USA) |
| Agu, Chukwuma (ABS Biotechnologies GmbH 202401 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
ABS Biotechnologies GmbH |
Austria |
| Aguiar, Sebastian (Samsara Therapeutics 201902 COO + Founder) |
Chief Operating Officer (COO) |
|
|
| Aguilar, Luc (L’Oréal 201402 Head of Biotechnologies Dept) |
President/Director/Head Business Group/Unit/Division |
L’Oréal (Group) |
France |
| Ahlers, Benedikt (Florenus AG 200912– Executive Director + Founder before IP Bewertungs AG Head Sales + Developm) |
Board member, executive |
Florenus AG |
Germany |
| Ahlers, Sabine |
n. a. |
DEWB AG |
Germany |
| Ahmed, Nadim (BMS 202109 EVP) |
President/Director/Head Business Group/Unit/Division |
Bristol Myers Squibb (BMS) (Group) |
United States (USA) |
| Ahnfeld, Oliver (Provirex 201911– Managing Director) |
Managing Director |
Provirex Genome Editing Therapies GmbH |
Germany |
| Ahomäki, Satu (Orion Corp 202001 SVP Commercial Operations) |
Chief Commercial Officer (CCO) |
Orion Corporation (Group) |
Finland |
| Ahrens, Nikolai (Turos Capital 2018– Founder + CEO + LifeScience Connect 2020 Founder) |
n. a. |
Turos Capital AG |
Switzerland |
| Ahrent, Esther (Olympus Life + Material Science Europa GmbH 200704 Section Manager Marketing Comm Microscopy) |
n. a. |
Olympus (Group) |
Germany |
| Aigner, Ilse (Germany (govt) 201101 Minister BMELV) |
Minister |
Germany (govt) |
Germany |
| Aiguabella Font, Nuria (Bayer 202108 Global Communications Bayer Pharma New Modalities) |
Public Relations Manager / Investor Relations Manager |
Bayer (Group) |
Germany |
| Aisher, Patrick (Kinled 202104 at Kinled Austria) |
Investment Manager |
Kinled (Group) |
Austria |
| Aiwanger, Hubert (Bavaria (govt) 201904 State Minister of Economic Affairs + Regional Development + Energy) |
Minister |
Bavaria (govt region) |
Germany |
| Akay, Ingrid Teigland (Hadean Ventures 201604 Managing Director) |
Managing Director |
Hadean Ventures AS |
Norway |
| Akhmedov, Murodzhon (BigOmics 202203 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
BigOmics Analytics S.A. |
Switzerland |
| Akkaraju, Srinivas (Srini) (Samsara BioCaptial 2016– Founder before Sofinnova Ventures + New Leaf Venture Partners) |
Investment Manager |
Samsara BioCapital (US) |
United States (USA) |
| Akkerman, Ina (mei:do concepts GmbH 201211 Director Marketing + Communication before Norgenta) |
Public Relations Manager / Investor Relations Manager |
mei:do concepts GmbH |
Germany |
| Al-Halabi-Frenzel, Laila (Abcalis GmbH 202312 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Abcalis GmbH |
Germany |
| Al-Olayan, Abdurahman (Dammam Valley 202209 CEO) |
Chief Executive Officer (CEO) |
Saudi Arabia (govt) |
Saudi Arabia |
| Al-Wakeel, Yasir (Kronos Bio 202008– CFO + Head of CorpDev before Neon Therapeutics + Merrimack Pharma + Credit Suisse) |
Chief Financial Officer (CFO) |
Kronos Bio Inc. (Nasdaq: KRON) |
United States (USA) |
| Alambeigi, Behrouz (Genetek Biopharma 201805 Managing Director + Co-Founder) |
Managing Director |
Genetek Biopharma GmbH |
Germany |
| Alanine, Alexander (Bactevo 201704– COO before Roche) |
Chief Operating Officer (COO) |
Astellas (Group) |
United Kingdom (GB) |
| Alatovic, Jasmina (BioNTech 202005 Senior Manager Global External Communications) |
Public Relations Manager / Investor Relations Manager |
BioNTech (Group) |
Germany |
| Albani, Stephan (Univ Oldenburg 201101 Managing Director HörTech gGmbH + Hörzentrum Oldenburg GmbH) |
Managing Director |
University of Oldenburg (Carl von Ossietzky University) |
Germany |
| Albayrak, Celal (ALRISE Biosystems 201005 Managing Director) |
Managing Director |
Alrise Biosystems GmbH |
Germany |
| Albermann, Kaj (Biomax Informatics 201804 Project Manager) |
Support Manager / Service Manager |
Biomax (Group) |
Germany |
| Albert, Winfried (AdnaGen 200810 Managing Director before COO + CSO) |
Managing Director |
Qiagen (Group) |
Germany |
| Alberti, Claudio (GenomSys 201909 CTO + Co-Founder) |
Chief Technology/Technical Officer (CTO) |
GenomSys S.A. |
Switzerland |
| Albiez, Michael (Zeiss 202303 Head of Zeiss Research Microscopy Solutions) |
President/Director/Head Business Group/Unit/Division |
Carl Zeiss (Group) |
Germany |
| Albiez, Peter (Pfizer 202007 Country Manager Germany) |
Regional manager |
Pfizer (Group) |
Germany |
| Albig, Torsten (Schleswig-Holstein (govt) 201703 Minister President) |
Minister |
Schleswig-Holstein (govt region) |
Germany |
| Albrecht, Klaus-Dieter (Synexus 201303– Managing Director fo Synexus Germany) |
Managing Director |
Synexus (Group) |
Germany |
| Albrecht, Uwe (Mediconomics 201704 Managing Director) |
Managing Director |
Mediconomics GmbH |
Germany |
| Albrecht, Wolfgang (HepaRegenix 201602– Managing Director) |
Managing Director |
HepaRegenix GmbH |
Germany |
| Aldag, Jörn (Hookipa Biotech 201606– CEO before Uniqure/AMT + Evotec + MAN GHH) |
Chief Executive Officer (CEO) |
Hookipa (Group) |
Austria |
| Alder, Matthias (Autolus 201707– CBO + General Counserl before Sucampp + Cytos Biotechnology + Micromet + Cooley LLP) |
Chief Business Officer (CBO) |
Autolus Therapeutics plc (Nasdaq: AUTL) |
United Kingdom (GB) |
| Aleotti, Lucia (Menarini 201611 Group Chairman) |
Chief Executive Officer (CEO) |
Menarini (Group) |
Italy |
| Alexakis, Domenico P. (Swiss Biotech Association 201611 CEO) |
Chief Executive Officer (CEO) |
Swiss Biotech Association (SBA) |
Switzerland |
| Alexander, David (Adecco 201709 President North America Financa, Office + Healthcare businesses) |
President/Director/Head Business Group/Unit/Division |
Adecco (Group) |
Switzerland |
| Alexander, Sebastian (Chorlex Pharmaceuticals GmbH 201511– Managing Director) |
Managing Director |
Chorlex Pharmaceuticals GmbH |
Germany |
| Alexandre, Leslie (Life Science Washington 202108 CEO) |
Chief Executive Officer (CEO) |
Life Science Washington |
United States (USA) |
| Alexandrov, Alexander (MYR GmbH 201203 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Gilead Sciences (Group) |
Germany |
| Alexandrov, Theodore (EMBL 201410– Team Leader at EMBL Heidelberg before Univ Bremen) |
Researcher (university / research institute) |
EMBL (European Molecular Biology Laboratory) |
Germany |
| Alghabban, Amer (Merck (DE) 201402 Director Global Quality Assurance Auditing of Merck Serono) |
n. a. |
Merck (DE) (Group) |
Germany |
| Ali, Mohammed (Boehringer 202002 Global Head of Digital Development Global Clinical Operations) |
n. a. |
Boehringer Ingelheim (Group) |
Germany |
| Alici, Aysel (Caprotec 201210 Sales Manager) |
Sales Manager / Marketing Manager |
Caprotec Bioanalytics GmbH |
Germany |
| Alilovic, Sasa (Sascha) (SHS 202004– Managing Partner joined 2018 as Partner before MorphoSys + Siemens) |
Managing Partner (investment firm) |
SHS Capital (Group) |
Germany |
| Alland, Leila (Affimed 201803– CMO before Tarveda Therapeutics + AstraZeneca + BMS + Novartis) |
Chief Medical Officer (CMO) |
Affimed (Group) |
Germany |
| Alldread, Richard (Lonza 201107 Head Technology Development + Strategic Projects at Lonza Development Services) |
Technical Manager |
Lonza (Group) |
Switzerland |
| Allemond, Pierre (Protein Metrics 201510– VP European Sales before Biovia/Dassault Systèmes + Accelrys + Chemspeed) |
Sales Manager / Marketing Manager |
Insightful Science (Group) |
Switzerland |
| Allen, Chris (Broughton Laboratories 2011– Managing Director joind as Co-Founder 2006 before Sciantec Analytical) |
Managing Director |
Broughton Laboratories (GB) |
United Kingdom (GB) |
| Allen, Keith (Syngenta Biotechnology Inc. 200604) |
n. a. |
Syngenta (Group) |
Switzerland |
| Allen, Mark (Elevian 202209 CEO) |
Chief Executive Officer (CEO) |
Elevian |
|
| Allerberger, Franz (Austria (govt) 201005 Head Human Medicine Div of AGES) |
Professor |
Austria (govt) |
Austria |
| Alles, Mark (Celgene 201306 EVP + Global Head Hematology + Oncology) |
President/Director/Head Business Group/Unit/Division |
Bristol Myers Squibb (BMS) (Group) |
United States (USA) |
| Alles, Melanie (CSL Behring 201910– Senior Manager Global Pathogen Safety Suppart before Deutsche Bank) |
n. a. |
CSL (Group) |
Australia |
| Allgaier, Hermann (Merckle Biotec 200503 Managing Director) |
Managing Director |
Teva (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
